SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page910111213141516Next Page
2026-09-16HALO144MATTHEW POSARD plan to sell securities of HALOZYME THERAPEUTICS INC under Form 144MEDIUM
MATTHEW POSARD filed Form 144 to notify SEC of plan to sell 34226 units of HALOZYME THERAPEUTICS INC securities around 2026-09-16, with aggregate market value of $3,636,512.50. The total outstanding units is 113498000.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Large CapBiotechnology
Previous Page910111213141516Next Page